Clinical trial
"The Once A Day Protease Inhibitor Regimens"
NCT00242216 · The University of Texas Health Science Center, Houston, Other · Completed
Key facts
| NCT number | NCT00242216 |
|---|---|
| Title | "The Once A Day Protease Inhibitor Regimens" |
| Official title | "PIQD: The Once a Day Protease Inhibitor Regimens." Ritonavir Boosted Atazanavir vs. Ritonavir Boosted Fosamprenavir Used in Combination With Tenofovir and Emtricitabine in HIV-1 Infected Antiretroviral Treatment-Naïve Patients. |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | ritonavir-boosted atazanavir, ritonavir-boosted fosamprenavir |
| Enrollment | 76 |
| Start date | May 1, 2004 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Oct 19, 2005 |
| Last update posted | Jan 15, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: